INFECTIONS IN BURN PATIENTS

Feigin and Cherry's Textbook of Pediatric Infectious Diseases, Sixth Edition

Volumn , Issue , 2009, Pages 1139-1151

  Patel, Janak A ^a,b   Williams Bouyer, Natalie ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84906797470     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4044-6.50092-3     Document Type: Chapter

References (126)

1. S. Abdi, D.N. Herndon, J. McGuire, et al. (1990) Time course of alterations in lung lymph and bronchial blood flows after inhalation injury. J. Burn Care Rehabil. 11 510-515.
2. S. Albertson, D.G. Greenhalgh, M.P. Breeden, et al. (1994) Cardiac abnormalities in children with burns: An autopsy analysis. J. Burn Care Rehabil. 15 401-404.
3. M.C. Albrecht, M.E. Griffith, C.K. Murray, et al. (2006) Impact of Acinetobacter infection on the mortality of burn patients. J. Am. Coll. Surg. 203 546-550.
4. American Burn Association. Factsheet. http://www.ameriburn.org/resources_factsheet.php (9/20/2007).
5. G.F. Babcock, J.W. Alexander and G.D. Warden (1990) Flow cytometric analysis of neutrophil subsets in thermally injured patients developing infection. Clin. Exp. Immunol. 54 117-125.
6. D. Balogh, H. Lammer, E. Kornberger, et al. (1992) Neopterin plasma levels in burn patients. Burns 18 185-188.
7. R.C. Barber, L.Y. Chang, B.D. Arnoldo, et al. (2006) Innate immunity SNPs are associated with risk for severe sepsis after burn injury. Clin Med Res 4 250-255.
8. P. Baron, L.D. Traber, D.L. Traber, et al. (1994) Gut failure and translocation following burn and sepsis. J. Surg. Res. 57 197-204.
9. J.P. Barret and D.N. Herndon (2003) Effects of burn wound excision on bacterial colonization and invasion. Plast. Reconstr. Surg. 111 744-750.
10. J.P. Barrett, P.I. Ramzy, J.P. Heggers, et al. (1999) Topical nystatin powder in severe burns: A new treatment for angioinvasive fungal infections refractory to other topical and systemic agents. Burns 25 505-508.
11. R.E. Barro, C.Z. Wang, R.A. Cox, et al. (1992) Cellular sequence of tracheal repair in sheep post smoke inhalation injury. Lung 170 331-338.
12. T.W. Baskin, A. Rosenthal and B.A. Pruitt (1976) Acute bacterial endocarditis: A silent source of sepsis in the burn patient. Ann. Surg. 184 618.
13. C.H. Beard, C.D. Ribeiro and D.M. Jones (1975) The bacteremia associated with burns surgery. Br. J. Surg. 62 638-641.
14. R. Bjerknes and H. Vindenes (1989) Neutrophil dysfunction after thermal injury- alteration of phagolysosomal acidification in patients with large burns. J. Trauma 15 71-81.
15. B. Bourdarias, G. Perro, M. Cutillas, et al. (1996) Herpes simplex virus infection in burned patients: Epidemiology of 11 cases. Burns 22 287-290.
16. B.L. Bowers, G.F. Purdue and J.L. Hunt (1991) Paranasal sinusitis in burn patients following nasotracheal intubation. Arch. Surg. 126 1411-1412.
17. R.J. Byers, P.S. Hasleton, A. Quigley, et al. (1996) Pulmonary herpes simplex in burns patients. Eur. Respir. J. 9 2313-2317.
18. R.C. Cartotto, D.B. Macdonald and S.M. Wasan (1998) Acute bacterial endocarditis following burns: Case report and review. Burns 24 363-373.
19. D.M. Caruso, K.N. Foster, S.A. Blome-Eberwein, et al. (2006) Randomized clinical study of Hydrofiber dressing with silver or silver sulfadiazine in the management of partial-thickness burns. J. Burn Care Rehabil. 27 298-309.
20. C. Childs, V. Edwards-Jones, D.M. Heathcote, et al. (1994) Patterns of Staphylococcus aureus colonization, toxin production, immunity and illness in burned children. Burns 20 514-521.
21. N. Cook (1998) Methicillin-resistant Staphylococcus aureus versus the burn patient. Burns 24 91-98.
22. P. Coursaget, G. Lesage, B. Simpson, et al. (1991) Incidence of hepatitis C virus infection in burn patients: Detection of anti-C100, anti-C33c and anti-Core antibodies. Biomed Pharmacother 45 445-449.
23. G.S. Deepe Jr., B.C. MacMillan and C.C. Linnemann Jr. (1982) Unexplained fever in burned patients due to cytomegalovirus infection. JAMA 248 2299-2301.
24. M.H. Desai, D.N. Herndon and S. Abston (1987) Candida infection in massively burned patients. J. Trauma 27 1186-1188.
25. E.A. Dietich, D. Xu and L. Qi (1990) Different lymphocyte compartments respond differently to mitogenic stimulation after thermal injury. Ann. Surg. 211 72-77.
26. O. Ergün, A. Celik, G. Ergün, et al. (2004) Prophylactic antibiotic use in pediatric burn units. Eur J Pediatr Surg 14 422-426.
27. S. Erol, U. Altoparlak, M.N. Akcay, et al. (2004) Changes in microbial flora and wound colonization in burned patients. Burns 30 357-361.
28. E.B. Evans (2007) Musculoskeletal changes secondary to thermal burns. D.N. Herndon (Eds) Total Burn Care London: W. B. Saunders 652-666.
29. E. Faist, W. Ertel, C.C. Baker, et al. (1989) Terminal B-cell maturation and immunoglobulin (Ig) synthesis in vitro in patients with major injury. J. Trauma 29 2-9.
30. C.C. Finnerty, D.N. Herndon and M.G. Jeschke (2007) Inhalation injury in severely burned children does not augment the systemic inflammatory response. Crit. Care 11 R22.
31. C.C. Finnerty, D.N. Herndon, R. Przkora, et al. (2006) Cytokine expression profile over time in severely burned pediatric patients. Shock 26 13-19.
32. R.Y. Fleming, S.T. Zeigler, M.A. Walton, et al. (1991) Influence of burn size on the incidence of contamination of burn wounds by fecal organisms. J. Burn Rehabil. 12 510-515.
33. D. Furniss, S. Gore, B. Azadian, et al. (2005) Acinetobacter is associated with acquired glucose intolerance in burn patients. J. Burn Care Rehabil. 26 405-408.
34. M.A. Gadd, J.F. Hansbrough, D.B. Hoyt, et al. (1989) Defective T-cell surface antigen expression after mitogen stimulation: An index of lymphocyte dysfunction after controlled murine injury. Ann. Surg. 29 112-118.
35. J.J. Gallagher, N. Williams-Bouyer, C. Villarreal, et al. (2007) Total Burn Care. D.N. Herndon (Eds) Treatment of infections in burns Philadelphia: W. B. Saunders 143.
36. H. Gasser, E. Paul, H. Redl, et al. (1991) Loss of plasma antioxidants after burn injury. Circ. Shock 34 13. Abstract.
37. P. Gastmeier, O. Weigt, D. Sohr and H. Rüden (2002) Comparison of hospital-acquired infection rates in paediatric burn patients. J. Hosp. Infect. 52 161-165.
38. E.J. Giamarellos-Bourboulis, E. Xirouchaki and H. Giamarellou (2001) Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii. Diagn. Microbiol. Infect. Dis. 40 117-120.
39. R.A. Gibbons, O.M. Martinez, R.C. Lim, et al. (1989) Reduction in HLA-DR, HLA-DQ, and HLA-DP expression by Leu-M3 − cells. Clin. Exp. Immunol. 75 371-375.
40. C.S. Gotschall, M.I. Morrison and M.R. Eichelberger (1998) Prospective, randomized study of the efficacy of Mepitel on children with partial-thickness scalds. J. Burn Care Rehabil. 19 279-283.
41. J. Goverman, J.M. Weber, T.J. Keaney, et al. (2007) Intravenous colistin for the treatment of multi-drug resistant, gram-negative infection in the pediatric burn population. J. Burn Care Res. 28 421-426.
42. D. Greenhalgh (2007) Wound healing. D.N. Herndon (Eds) Total Burn Care Philadelphia: W. B. Saunders 559-578.
43. P. Gruteke, A. van Belkum, L.M. Schouls, et al. (1996) Outbreak of group A streptococci in a burn center: Use of pheno- and genotypic procedures for strain tracking. J. Clin. Microbiol. 34 114-118.
44. B.H. Hamory (1989) Nosocomial sepsis related to intravascular access. Crit. Care Nurs. J. 11 58-65.
45. J.F. Hansbrough, R. Zapata-Sirvent and D. Hoyt (1990) Postburn immune suppression: An inflammatory response to the burn wound? J. Trauma 30 671-675.
46. F.G. Hayden, H.N. Himmel and J.P. Heggers (1994) Herpes virus infections in burn patients. Chest 106(Suppl), 15S-21S.
47. J.P. Heggers, M.J. Muller, E. Elwood and D.N. Herndon (1995) Ascariasis pneumonitis: A potentially fatal complication in smoke inhalation injury. Burns 21 149-151.
48. J.P. Heggers, M.C. Robson, D.N. Herndon and M.H. Desai (1989) The efficacy of nystatin combined with topical microbial agents in the treatment of burn wound sepsis. J. Burn Care Rehab. 10 508-511.
49. J.P. Heggers and M.C. Robson (1978) The emergence of silver sulfadiazine resistant Pseudomonas aeruginosa. Burns 5 184-187.
50. J.P. Heggers and M.C. Robson (Eds) (1991) Quantitative Bacteriology: Its Role in the Armamentarium of the Surgeon 1st ed. Boca Raton, FL: CRC Press 1-139.
51. J.P. Heggers, J.A. Sazy, B.D. Stenberg, et al. (1991) Bactericidal and wound healing properties of sodium hypochlorite. The 1991 Lindberg Award. J. Burn Care Rehab. 12 420-424.
52. D.N. Herndon, L.D. Traber, H. Linares, et al. (1986) Etiology of the pulmonary pathophysiology associated with inhalation injury. Resuscitation 14 43-59.
53. P.G. Higgins, H. Wisplinghoff, D. Stefanik, et al. (2004) In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains. Antimicrob. Agents Chemother. 48 1586-1592.
54. D.M. Jackson (1953) The diagnosis of the depth of burning. Br. J. Surg. 40 588-596.
55. J. James, H.W. Hofland, E.S. Borgstein, et al. (2003) The prevalence of HIV infection among burn patients in a burn unit in Malawi and its influence on outcome. Burns 29 55-60.
56. M.G. Jeschke, R.P. Mlcak, C.C. Finnerty, et al. (2007) Burn size determines the inflammatory and hypermetabolic response. Crit. Care 11 R90.
57. E.B. Jones (1995) Prophylactic anti-lipopolysaccharide freeze-dried plasma in major burns: A double blind controlled trial. Burns 21 267-272.
58. R.J. Kagan, A. Bratescu, O. Jonason, et al. (1989) The relationship between the percentage of circulating B cells, corticosteroid levels, and other immunologic parameters in thermally injured patients. J. Trauma 29 208-213.
59. T. Kaufman, R.A. Neuman and A. Weinberg (1989) Is postburn dermal ischemia enhanced by oxygen free radicals? Burns 15 291-294.
60. G.P. Kealey, J.F. Bale, R.G. Strauss, et al. (1987) Cytomegalovirus infection in burn patients. J. Burn Care Rehabil. 8 543-545.
61. J.L. Kelly, A. Lyons, C.C. Soberg, et al. (1997) Anti-interleukin-10 antibody restores burn-induced defects in T-cell function. Surgery 122 146-152.
62. M. Killer, W. Konig, J. Brom, et al. (1989) Studies on the mechanisms of granulocyte dysfunctions in severely burned patients—evidence for altered leukotriene generation. J. Trauma 29(435), 45.
63. J. Koller and M. Orsag (1998) Our experience with the use of cerium sulphadiazine in the treatment of extensive burns. Acta. Chir. Plast. 40 73-75.
64. R. Konigova, Z. Konickova and I. Bouska (1979) Clinical forms of endotoxin in burns. Scand. J. Plast. Reconstr. Surg. 13 61-62.
65. T.J. Krizek, J.H. Davis, J.D. DesPrez, et al. (1967) Topical therapy of burns—experimental evaluation. Plast. Reconstr. Surg. 39 248.
66. J.O. Kucan and E.C. Smoot (1993) Five percent mafenide acetate solution in the treatment of thermal injuries. J. Burn Care Rehabil. 14 153-158.
67. K.K. Lai, A.L. Kelley, Z.S. Melvin, et al. (1998) Failure to eradicate vancomycin-resistant enterococci in a university hospital and the cost of barrier precautions. Infect. Control Hosp. Epidemiol. 19 647-652.
68. J.M. Larkin and J.A. Moylan (1975) Tetanus following a minor burn. J. Trauma 15 546-548.
69. E.J. Law, K. Blecher and J.M. Still (1994) Enterococcal infection as cause of morbidity and mortality in patients with burns. J. Burn Care Rehabil. 15 236-239.
70. J.C. Lawrence, J.S. Cason and A. Kidson (1982) Evaluation of phenoxetol-chlorhexidine cream as prophylactic agent in burns. Lancet 24 524-525.
71. M. Lesseva, B.P. Girgitzova and C. Bojadjiev (1994) Beta-hemolytic streptococcal infections in burned patients. Burns 20 422-425.
72. C.C. Linnemann Jr. and B.G. MacMillan (1981) Viral infections in pediatric burn patients. Am. J. Dis. Child. 135 750-753.
73. X.S. Liu, Z.C. Yang, Z.H. Luo, et al. (1994) Clinical significance of the change in blood monocyte interleukin-1 production in vitro in severely burned patients. Burns 20 302-306.
74. O. Ljunghusen, J. Lundahl, H. Nettelblad, et al. (1996) Endotoxemia and complement activation after severe burn injuries—effect on leukocytes, soluble selectins, and inflammatory cytokines. Inflammation 20 229-241.
75. D.P. Mackie, W.A. van Hertum, T. Schumburg, et al. (1992) Prevention of infection in burns: Preliminary experience with selective decontamination of the digestive tract in patients with extensive injuries. J. Trauma 32 570-575.
76. M.D. Maldonado, A. Venturoli, A. Franco, et al. (1991) Specific changes in peripheral blood lymphocyte phenotype from burn patients: Probable origin of the thermal injury-related lymphocytopenia. Burns 17 188-192.
77. A.T. McManus, A.D. Mason Jr., W.F. McManus and B.A. Pruitt Jr. (1994) A decade of reduced gram-negative infections and mortality associated with improved isolation of burned patients. Arch. Surg. 129 1306-1309.
78. J.A. Mendelson (1997) The management of burns under conditions of limited resources using topical aqueous Sulfamylon (mafenide) hydrochloride spray. J. Burn Care Rehabil. 18 238-244.
79. E.U. Mian, R. Gianfaldoni and M. Mian (1992) The use of intravenous immunoglobulins in patients with severe burns. Clin. Ther. 141 75-81.
80. D.C. Mills II, L.W. Roberts, A.D. Mason Jr., et al. (1988) Suppurative chondritis: Its incidence, prevention, and treatment in burn patients. Plast. Reconstr. Surg. 82 267-276.
81. J.A. Moncrief (1979) Topical antibacterial treatment of the burn wound. C.P. Artz, J.A. Moncrief, B.A. Pruitt, Jr. (Eds) Burns: A Team Approach Philadelphia: W. B. Saunders 250-269.
82. F.D. Moore Jr. and C.F. Davis (1989) Monocyte activation after burns and endotoxemia. J. Surg. Res. 46 350-354.
83. A.R. Moritz and F.C. Henrique Jr. (1947) Studies of thermal injury: The relative importance of time and surface temperature in the causation of cutaneous burns. Am. J. Pathol. 23 695-720.
84. A.M. Munster (1970) Alterations of the host defense mechanism in burns. Surg. Clin. North Am. 50 1217-1225.
85. A.M. Munster, K.T. Moran, J. Thupari, et al. (1987) Prophylactic intravenous immunoglobulin replacement in high-risk burn patients. J. Burn Care Rehabil. 8 376-380.
86. A.N. Neely, W.L. Smith and G.D. Warden (1998) Efficacy of a rise in C-reactive protein serum levels as an early indicator of sepsis in burned children. J. Burn Care Rehabil. 19 102-105.
87. R.J. Noelle and E.C. Snow (1991) T helper cell-dependent B cell activation. FASEB J 5 2770-2776.
88. M.D. Obritsch, D.N. Fish, R. MacLaren, et al. (2005) Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: Epidemiology and treatment options. Pharmacotherapy 25 1353-1364.
89. Y.S. Ong, M. Samuel and C. Song (2006) Meta-analysis of early excision of burns. Burns 32 145-150.
90. Y. Ono, O. Kunii, H. Suzuki, et al. (1994) Opsonic activity of sera and blister fluid from severely burned patients evaluated by a chemiluminescence method. Microbiol. Immunol. 38 373-377.
91. B.C. Organ, A.C. Antonacci, J. Chio, et al. (1988) Changes in lymphocyte number and phenotype in seven lymphoid compartments after thermal injury. Ann. Surg. 210 78-89.
92. T.L. Palmieri, D.M. Caruso, K.N. Foster, et al. (2006) Effect of blood transfusion on outcome after major burn injury: A multicenter study. Crit. Care Med. 34 1062-1067.
93. D.H. Parks, H.A. Linares and P.D. Thompson (1982) Surgical management of burn wound sepsis. Surg. Gynecol. Obstet. 153 374-376.
94. B.A. Pruitt and F.D. Foley (1973) The use of biopsies in burn patient care. Surgery 73 887-897.
95. C.M. Reardon, T.P. Brown, A.J. Stephenson, et al. (1998) Methicillin-resistant Staphylococcus aureus in burns patients—Why all the fuss? Burns 24 393-397.
96. H.O. Rennekampff and K. Hamprecht (2006) Cytomegalovirus infection in burns: A review. J. Med. Microbiol. 55 483-487.
97. B.M. Renz and R. Sherman (1993) Exposure of buttock burn wounds to stool in scald-abused infants and children: Stool-staining of eschar and burn wound sepsis. Am. Surg. 59 379-383.
98. E.J. Ridgway and K.D. Allen (1993) Clustering of group A streptococcal infections on a burn unit: Important lessons in outbreak management. J. Hosp. Infect. 25 173-182.
99. G.L. Rodgers, M.C. Fisher, A. Lo, et al. (1997) Study of antibiotic prophylaxis during burn wound débridement in children. J. Burn Care Rehabil. 18 342-346.
100. R.L. Rutan, D.L. Bjarnason, M.H. Desai, et al. (1992) Incidence of HIV seroconversion in paediatric burn patients. Burns 18 216-219.
101. T.M. Sasaki, O.W. Welch, D.N. Herndon, et al. (1979) Burn wound manipulation induced bacteremia. J. Trauma 19 46-48.
102. T. Schlager, J. Sadler, D. Weber, et al. (1994) Hospital-acquired infections in pediatric burn patients. South Med. J. 87 448-481.
103. B. Schluter, W. Konig, M. Koller, et al. (1991) Differential regulation of T- an B-lymphocyte activation in severely burned patients. J. Trauma 31 239-246.
104. R.L. Sheridan, J.M. Weber, L.G. Budkevich, et al. (1995) Candidemia in pediatric patients with burns. J. Burn Care Rehabil. 16 440-443.
105. R.T. Sherman (1970) The prevention and treatment of tetanus in the burn patient. Surg. Clin. North Am. 50 1277-1281.
106. J.A. Shilling (1968) Burn healing. Physiol. Rev. 48 374-423.
107. K.Z. Shiranin, B.A. Pruitt Jr. and A.D. Mason Jr. (1987) The influence of inhalation injury and pneumonia on burn mortality. Ann. Surg. 205 82-87.
108. M. Shoup, J.M. Weisenberger, J.L. Wang, et al. (1998) Mechanisms of neutropenia involving myeloid maturation arrest in burn sepsis. Ann. Surg. 228 112-122.
109. J.M. Stein and B.A. Pruitt Jr. (1970) Suppurative thrombophlebitis: A lethal iatrogenic disease. N. Engl. J. Med. 282 1452-1455.
110. L.L. Strock, M. Lee, R.L. Rutan, et al. (1990) Topical bactroban (Mupirocin): Efficacy in treating MRSA wounds infected with methicillin-resistant staphylococci. J. Burn Care Rehabil. 11 454-459.
111. R. Stuttmann, D. Hebebrand, M. Hartert, et al. (1991) [Prevention with pseudomonas immune globulin in burn injury patients with inhalation trauma: Does it have an effect on lung function and outcome]? Klin. Wochenschr. 69(Suppl 26), 168-177.
112. C. Teplitz (1979) The pathology of burns and the fundamentals of burn wound sepsis. C.P. Artz, J.A. Moncrief, B.A. Pruitt, Jr. (Eds) Burns—A Team Approach Philadelphia: W. B. Saunders 45.
113. E.E. Tredget, H.A. Shankowsky, A.M. Joffe, et al. (1992) Epidemiology of infections with Pseudomonas aeruginosa in burn patients: The role of hydrotherapy. Clin. Infect. Dis. 15 941-949.
114. E.E. Tredget, H.A. Shankowsky, A. Groeneveld, et al. (1998) A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds. J. Burn Care Rehabil. 19 531-537.
115. J. Utoh, T. Utsunomiya, T. Imamura, et al. (1989) Complement activation and neutrophil dysfunction in burned patients with sepsis—a study of two cases. Jpn. J. Surg. 19 462-467.
116. R.R. van Rijn, E.C. Kuijper and R.W. Kreis (1997) Seven-year experience with a “quarantine and isolation unit” for patients with burns. A retrospective analysis. Burns 23 345-348.
117. H.A. Vindenes and R. Bjerknes (1997) Impaired actin polymerization and depolymerization in neutrophils from patients with thermal injury. Burns 23 131-136.
118. W.L. Wahl, K.S. Ahrns, M.M. Brandt, et al. (2005) Bronchoalveolar lavage in diagnosis of ventilator-associated pneumonia in patients with burns. J. Burn Care Rehabil. 26 57-61.
119. J.P. Waymack, M.E. Jenkins, J.W. Alexander, et al. (1989) A prospective trial of prophylactic intravenous immune globulin for the prevention of infections in severely burned patients. Burns 15 71-76.
120. J.M. Weber, R.L. Sheridan, M.S. Pasternack, et al. (1997) Nosocomial infections in pediatric patients with burns. Am. J. Infect. Control 25 195-201.
121. M.J. Weinbren (1999) Review: Pharmacokinetics of antibiotics in burn patients. J. Antimicrob. Chemother. 44 319-327.
122. W.H. Weintrub, A.B. Lilly and J.G. Randolph (1974) A chickenpox epidemic in a pediatric burn unit. Surgery 76 490-494.
123. M.D. Winkelman and P.G. Galloway (1992) Central nervous system complications of thermal burns. A postmortem study of 139 patients. Medicine (Baltimore) 71 271-283.
124. B.F. Woolfrey, J.M. Fox and C.O. Quall (1981) An evaluation of burn wound quantitative microscopy. I. Quantitative eschar cultures. Am. J. Pathol. 75 532-537.
125. J. Yoon, C. Urban, C. Terzian, et al. (2004) In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 48 753-757.
126. D. Zhou, A.M. Munster and R.A. Winchurch (1992) Inhibitory effects of interleukin 6 on immunity: Possible implications in burns. Arch. Surg. 127 65-68.